Vimarsana
Biggest News Aggregation in the World

Page 9 - Nasdaq Rules News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Nasdaq Rules. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Nasdaq Rules Today - Breaking & Trending Today

Ironwood Pharmaceuticals : FORM OF TENDER AND SUPPORT AGREEMENT - Form 8-K - Vimarsana News

Ironwood Pharmaceuticals : FORM OF TENDER AND SUPPORT AGREEMENT - Form 8-K

FORM OF TENDER AND SUPPORT AGREEMENT This TENDER AND SUPPORT AGREEMENT , dated as of May 21, 2023, is entered into by and among Ironwood Pharmaceuticals, Inc., a Delaware... | May 23, 2023

VectivBio : IRONWOOD PHARMACEUTICALS, INC - Form 6-K - Vimarsana News

VectivBio : IRONWOOD PHARMACEUTICALS, INC - Form 6-K

IRONWOOD PHARMACEUTICALS, INC. and VECTIVBIO HOLDING AG Dated as of May 21, 2023 TABLE... | May 23, 2023

RedHill Biopharma Receives NASDAQ Notification Regarding Minimum Market Value of Publicly Held Shares Deficiency - Vimarsana News

RedHill Biopharma Receives NASDAQ Notification Regarding Minimum Market Value of Publicly Held Shares Deficiency

/PRNewswire/ -- RedHill Biopharma Ltd. (Nasdaq: RDHL) ("RedHill" or the "Company"), a specialty biopharmaceutical company, today announced that it has received...

Yumanity Therapeutics : Dosed First Patient in Phase 1/2 Clinical Study of VISTA-Targeting KVA12123 in Advanced Solid Tumors Initial KVA12123 Clinical Data Readout Anticipated by End of 2023 Closed $6 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules - Form 8-K - Vimarsana News

Yumanity Therapeutics : Dosed First Patient in Phase 1/2 Clinical Study of VISTA-Targeting KVA12123 in Advanced Solid Tumors Initial KVA12123 Clinical Data Readout Anticipated by End of 2023 Closed $6 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules - Form 8-K

Dosed First Patient in Phase 1/2 Clinical Study of VISTA-Targeting KVA12123 in Advanced Solid Tumors Initial KVA12123 Clinical Data Readout Anticipated by End of 2023 ... | May 11, 2023

Vox Royalty : NOTICE OF ANNUAL AND SPECIAL MEETING OF SHAREHOLDERS - Form 6-K - Vimarsana News

Vox Royalty : NOTICE OF ANNUAL AND SPECIAL MEETING OF SHAREHOLDERS - Form 6-K

NOTICE OF ANNUAL AND SPECIAL MEETING OF SHAREHOLDERS Date Thursday, June 8, 2023 ... | May 9, 2023